Antagonists of AT1R have been shown to be neuroprotective in the animal models of Alzheimer disease [51], Parkinson’s disease [52] and multiple sclerosis [33]. The gene discussed is AGTR1; the disease is early-onset autosomal dominant Alzheimer disease.